Iovance Biotherapeutics, Inc. (IOVA) Institutional Ownership & Insider Trading
292 institutions reported holding Iovance Biotherapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IOVAIovance Biotherapeutics, Inc.Follow IOVA — free
—
Price chart with a free account
- Market cap
- 6.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters292 institutions held 63.3% of the shares. Across filers that reported both quarters, shares held changed +5.9%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 292 | 287 | +5.9% | 120 | 37 | 60 | 29 |
| Mar 26 | 283 | 269 | +2.9% | 116 | 54 | 53 | 32 |
| Dec 25 | 260 | 261 | +22.3% | 98 | 38 | 59 | 28 |
| Sep 25 | 245 | 214 | -3.8% | 77 | 30 | 70 | 36 |
| Jun 25 | 244 | 220 | -8.1% | 83 | 32 | 66 | 74 |
| Mar 25 | 298 | 239 | -0.0% | 95 | 47 | 82 | 50 |
| Dec 24 | 298 | 241 | +1.4% | 96 | 33 | 81 | 27 |
| Sep 24 | 280 | 234 | -0.1% | 97 | 31 | 76 | 41 |
Iovance Biotherapeutics, Inc. — questions
- Who owns Iovance Biotherapeutics, Inc. stock?
- 292 institutions reported Iovance Biotherapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.2%), MHR FUND MANAGEMENT LLC (6.4%), STATE STREET CORP (5.4%).
Every figure on this page comes from Iovance Biotherapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.